Arcadia Biosciences (RKDA)
(Delayed Data from NSDQ)
$2.09 USD
+0.19 (9.99%)
Updated Apr 26, 2024 03:49 PM ET
4-Sell of 5 4
D Value C Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/9/24 |
---|---|
Current Quarter | -2.52 |
EPS Last Quarter | -2.48 |
Last EPS Surprise | 7.46% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -5.01 |
Next Year | NA |
EPS (TTM) | -10.78 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.20M | 1.50M | 6.50M | NA |
# of Estimates | 1 | 1 | 1 | NA |
High Estimate | 1.20M | 1.50M | 6.50M | NA |
Low Estimate | 1.20M | 1.50M | 6.50M | NA |
Year ago Sales | 1.51M | 1.39M | 5.66M | 6.50M |
Year over Year Growth Est. | -20.53% | 7.91% | 14.74% | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -2.52 | -1.47 | -5.01 | NA |
# of Estimates | 1 | 1 | 1 | NA |
Most Recent Consensus | -2.52 | -1.47 | -5.01 | NA |
High Estimate | -2.52 | -1.47 | -5.01 | NA |
Low Estimate | -2.52 | -1.47 | -5.01 | NA |
Year ago EPS | -3.83 | -2.64 | -11.02 | -5.01 |
Year over Year Growth Est. | 34.20% | 44.32% | 54.54% | NA |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | NA |
Up Last 30 Days | 1 | 0 | 0 | NA |
Up Last 60 Days | 1 | 0 | 0 | NA |
Down Last 7 Days | 0 | 0 | 0 | NA |
Down Last 30 Days | 0 | 1 | 1 | NA |
Down Last 60 Days | 0 | 1 | 1 | NA |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -2.52 | -1.47 | -5.01 | NA |
7 Days Ago | -2.52 | -1.47 | -5.01 | NA |
30 Days Ago | -2.55 | -1.44 | -4.92 | NA |
60 Days Ago | -2.55 | -1.44 | -4.92 | NA |
90 Days Ago | -2.55 | -1.44 | -4.92 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -2.52 | -1.47 | -5.01 | NA |
Zacks Consensus Estimate | -2.52 | -1.47 | -5.01 | NA |
Earnings ESP | 0.00% | 0.00% | 0.00% | NA |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -2.48 | -1.83 | -2.64 | -3.83 | NA |
Estimate | -2.68 | -2.67 | -4.92 | -6.35 | NA |
Difference | 0.20 | 0.84 | 2.28 | 2.52 | 1.46 |
Surprise | 7.46% | 31.46% | 46.34% | 39.69% | 31.24% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more